ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00179530
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : November 5, 2007
Sponsor:
Information provided by:
Beth Israel Deaconess Medical Center

Brief Summary:
To evaluate whether a 5-week relaxation response intervention influences the learning, memory or attention of healthy older adults.

Condition or disease Intervention/treatment Phase
Healthy Behavioral: Relaxation Response Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults
Study Start Date : May 1999
Actual Study Completion Date : September 2007



Intervention Details:
    Behavioral: Relaxation Response
    Relaxation training


Primary Outcome Measures :
  1. Evaluate whether a RR training program would decrease anxiety levels, improve attention, declarative memory performance in healthy older adults. [ Time Frame: 8 weeks ]

Secondary Outcome Measures :
  1. Evaluate whether a RR training program would decrease salivary cortisol levels in healthy older adults. [ Time Frame: 8 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 65 to 80 years od age
  • No prior or current psychiatric or neurological condition.
  • score above 24 on the Mini-Mental State Exam (MMSE)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00179530


Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Investigators
Principal Investigator: Jeffery A Dusek, PhD Beth Israel Deaconess Medical Center, Mind/Body Medical Institute

ClinicalTrials.gov Identifier: NCT00179530     History of Changes
Other Study ID Numbers: 2001-P-002249
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: November 5, 2007
Last Verified: November 2007

Additional relevant MeSH terms:
Hydrocortisone
Anti-Inflammatory Agents